Skip to main content
KROS logo

KROS

Keros Therapeutics, Inc.
$11.26 +0.38 (+3.49%) At close · Jul 2
Market Cap
$222.86M
Shares
19,791,837

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 150
Total Value: $201,006,084
Total Shares: 18,207,081
Showing 1–100 of 156 holdings by value · page 1 of 2

Institutional Ownership Trend

24 quarters

Holder Concentration

Across 150 13F filers · Δ vs Dec 31, 2025
Top Holder
13.2%
Jun 2023 → Mar 2026 · range 10.1% – 18.1%
+2.2 pts
Top 5
33.4%
Jun 2023 → Mar 2026 · range 33.4% – 45.8%
−0.5 pts
Top 10
51.5%
Jun 2023 → Mar 2026 · range 51.2% – 66.5%
−0.8 pts
HHI
419
Jun 2023 → Mar 2026 · range 395 – 655
Broadly held+23

Quarterly Activity

vs Dec 31, 2025
New
26
Increased
48
Decreased
55
Sold Out
42
Unchanged
21
Holder count: -16
Institutional value: -54.3%
Shares held: -15.8%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
Institution Sold Now Holds Open

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 100 of 156
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1664710 CUSIP 492327101 13F (30d) 2 filings 1 filers Visit website Investor relations